Home
C1 Uses
C1 Technology
Investors
Media Center
About
Careers
Contact Us
Vaccines
Antibodies
BIOSIMILARS
BIOBETTERS
BIOPHARMACEUTICALS
ENZYME THERAPIES
ANIMAL HEALTH
BIOTHERAPEUTIC MANUFACTURING
ENZYME CATALYSTS
C1 Expression System
Licensees / Collaborators
Manufacturing
R&D Facilities
The White Strain™
Analysts
Corporate Profile
Corporate Governance
Filings and Disclosures
Financial Statements
Proxy Statements
Stock Information
The Dyadic Story
Executives & Advisors
Careers
Contact Us
Events
Press Releases
Articles
Presentations
Scientific Publications
Video Gallery
Video Gallery
Please see Dyadic’s
YouTube
Channel for more Videos
(Nasdaq:DYAI) C1(TM) Technology Platform; The Right Science for Fighting Global Disease
Noble Virtual Conference - October 14, 2020
Dyadic Presents at BIO Investor Forum - October 2020
Dyadic and VTT Are Developing an Efficient New Production Method for Covid-19 Vaccines - September 2020
A Brief Look into Dyadic's Past and What the Future May Bring - September, 2020
Noble Capital Markets
Channelcheck c-suite series One-on-one with President & CEO Mark Emalfarb - June 24, 2020
Dyadic working with global research partners to express potential coronavirus vaccines using C1, May 15, 2020
Dyadic International, Inc. (OTCQX: DYAI) The Innovation Show – August 2017 | From Stonewashed Jeans to Lifesaving Genes
Dyadic Seeks to Bring Disruptive Technology to Biomanufacturing, The Bio Report, June 2017
